Author name: DrugChatter

How pharmaceutical brands are losing control of patient conversations, clinical narratives, and competitive positioning inside the black box of generative […]

Drug companies spend billions crafting brand narratives. AI is rewriting them in real time — and most manufacturers have no

How artificial intelligence is tracking, shaping, and sometimes undermining pharmaceutical brand strategy — and what drug companies need to do

A scan of hundreds of real-world questions on DrugChatter reveals a consistent pattern: patients are not just asking what a

There used to be a reliable playbook. You identified the twenty physicians who shaped prescribing behavior in a given therapeutic

A growing share of medication questions aren’t being asked in exam rooms. They’re being typed into search bars and forums

Across DrugChatter’s growing library of patient questions, a clear theme emerges: people are constantly trying to “switch” something in their

Patients are increasingly turning to online forums before their first dose—less for diagnosis, more for reassurance. The result is a

Every time ChatGPT answers a drug question, it may be doing something no FDA-approved ad campaign ever could — and

The standard pharmacovigilance process has a timing problem Adverse events travel faster than case reports. A patient posts about a

There’s a particular genre of drug question that never goes out of style: “What happens if I mess this up?”

There’s a pattern to mass adoption in pharma. First comes clinical data, then prescriber uptake, then—inevitably—the public internet asking the